Low dose IGF-I therapy improves insulin sensitivity but has no effect on VLDL apoB kinetics in type 1 diabetes.

E R Christ, P V Carroll, A M Umpleby, E Albany, P J Lumb, A S Wierzbicki, P H Sonksen, D L R Jones

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)A176 - A176
JournalDiabetologia
Volume43
Publication statusPublished - 2000

Cite this